Hendrik Schulze‐Koops

17.4k citations
288 papers · 9.4k · 2 hit papers · h-index 48

Impact in

  • Rheumatology top 0.1%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 0.5%
    • T-cell and B-cell Immunology
    • Immune Cell Function and Interaction
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • Rheumatoid Arthritis Research and Therapies 77
    • Systemic Lupus Erythematosus Research 25
    • Spondyloarthritis Studies and Treatments 22
    • T-cell and B-cell Immunology 39
    • Immune Cell Function and Interaction 26

Hendrik Schulze‐Koops

271 papers receiving 9.1k citations

Hendrik Schulze‐Koops's Hit Papers

Trial of Tocilizumab in Giant-Cell Arteritis 2017 · 831 citations
8310+4+9Years since publication250500750

Peers

Hendrik Schulze‐Koops
Comparison fields: 5 of 140
  • Rheumatology 3.2k
  • Immunology 2.8k
  • Hematology 1.1k
  • Genetics 529
  • Physiology 222
Replace Naoyuki Kamatani with:
Naoyuki Kamatani Japan
Nobuyuki Miyasaka Japan
Reinhard Voll Germany
Robert I. Fox United States
Keith B. Elkon United States
Raphaela Goldbach‐Mansky United States
G Steiner Austria
Ellen M. Gravallese United States
Robert P. Kimberly United States
Javier Martı́n Spain
Hendrik Schulze‐Koops relative to Naoyuki Kamatani Japan Naoyuki Kamatani's profile →
Citations per field
00.5×1.5×2.5×
Naoyuki Kamatani · 1×
Citations per year

Countries citing papers authored by Hendrik Schulze‐Koops

Since Specialization
Citations

This map shows the geographic impact of Hendrik Schulze‐Koops's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Schulze‐Koops with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Schulze‐Koops more than expected).

Fields of papers citing papers by Hendrik Schulze‐Koops

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Schulze‐Koops. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Schulze‐Koops. The network helps show where Hendrik Schulze‐Koops may publish in the future.

Co-authors

The 25 scholars most cited alongside Hendrik Schulze‐Koops, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hendrik Schulze‐Koops Line = papers co-authored together Hendrik Schulze‐Koops links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 288 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trial of Tocilizumab in Giant-Cell Arteritis
Hit paper breakdown →
2017831
2
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Hit paper breakdown →
2012801
3 2010372
4 2007293
5 2013272
6 1999253
7 2005249
8
The central role of T cells in rheumatoid arthritis.
2008236
9 2001225
10 2018218
11 1995218
12 2014156
13 2020154
14 2017137
15 2005133
16 2021124
17 1995114
18 199891
19 199288
20 201187

About Hendrik Schulze‐Koops

Hendrik Schulze‐Koops is a scholar working on Rheumatology, Immunology, Pulmonary and Respiratory Medicine, Hematology and Molecular Biology, having authored 288 papers that have together received 9.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (77 papers), T-cell and B-cell Immunology (39 papers), Vasculitis and related conditions (35 papers), Autoimmune and Inflammatory Disorders Research (33 papers), Immune Cell Function and Interaction (26 papers), Monoclonal and Polyclonal Antibodies Research (25 papers), Systemic Lupus Erythematosus Research (25 papers) and Spondyloarthritis Studies and Treatments (22 papers). The work is most often cited by research in Rheumatology (3.2k citations), Immunology (2.8k citations), Hematology (1.1k citations), Genetics (529 citations) and Physiology (222 citations). Hendrik Schulze‐Koops has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Alla Skapenko, Peter E. Lipsky, Joachim R. Kalden, Jan Leipe, Martin Aringer, Laurie S. Davis, John J. Cush, Andrew P. Cope, Georg Schett and Claudia Dechant. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, RMD Open, The Journal of Immunology and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact